febuxostat
Showing 1 - 25 of 52
Gout Trial in Taipei (Placebo, AC-201, Febuxostat)
Completed
- Gout
- Placebo
- +2 more
-
Taipei, TaiwanTaipei Veteran General Hospital (TVGH)
Jun 2, 2022
Hyperuricemia Trial in Guangzhou (Febuxostat, Placebo)
Recruiting
- Hyperuricemia
- Febuxostat
- Placebo
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Oct 20, 2020
Hyperuricemia and Diabetic Nephropathy
Not yet recruiting
- Hyperuricemia
- Diabetic Nephropathies
- Febuxostat
- (no location specified)
Mar 12, 2021
Uric Acid Stones, Hyperuricemia Trial in Shanghai (Febuxostat, Uralyt-U)
Unknown status
- Uric Acid Stones
- Hyperuricemia
- Febuxostat
- Uralyt-U
-
Shanghai, Shanghai, ChinaDepartment of Nephrolgoy, Shanghai 10th People's Hospital
Apr 16, 2020
Prehypertension, Gout, Pulse Wave Velocity Trial in San Diego (Febuxostat)
Completed
- Prehypertension
- +4 more
- Febuxostat
-
San Diego, CaliforniaUniverisity Of California San Diego
Nov 26, 2019
Oxidative Stress, Endothelial Function, Cardiovascular System Trial in Brussels (Placebos, Febuxostat, Rasburicase)
Completed
- Oxidative Stress
- +3 more
- Placebos
- +2 more
-
Brussels, Belgique, BelgiumErasme Hospital
Feb 27, 2020
Gout Flare Trial in Beijing (simiaowan, , febuxostat)
Unknown status
- Gout Flare
- simiaowan
- +2 more
-
Beijing, Beijing, ChinaGuang'anmen Hospital
Aug 28, 2019
Hyperuricemia Trial in Karachi (Febuxostat, Allopurinol)
Completed
- Hyperuricemia
- Febuxostat
- Allopurinol
-
Karachi, Sindh, PakistanDow University of Health Sciences
Jul 30, 2019
Gout Trial in Suzhou (Colchicine, Febuxostat, SHR4640)
Completed
- Gout
- Colchicine
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Aug 6, 2019
Chronic Kidney Disease, Hyperuricemia, Abnormal Renal Function Trial in Shanghai (Febuxostat, Benzbromarone)
Completed
- Chronic Kidney Disease
- +2 more
- Febuxostat
- Benzbromarone
-
Shanghai, Shanghai, ChinaDepartment of Nephrology & Rheumatology, Shanghai Tenth People's
Jul 23, 2019
Asymptomatic Hyperuricemia Trial in Glendale, Baltimore (Verinurad, Febuxostat, Dapagliflozin)
Bioequivalence Trial in Montréal (Febuxostat, Adenuric)
Completed
- Bioequivalence
- Febuxostat
- Adenuric
-
Montréal, Quebec, CanadaAltasciences Company Inc.
Jul 5, 2019
Gout Trial in Tampa (Magnetic Resonance Imaging, Febuxostat, Colchicine)
Completed
- Gout
- Magnetic Resonance Imaging
- +2 more
-
Tampa, FloridaUniversity of South Florida Medical Clinics
Jul 18, 2019
Contrast-induced Nephropathy, Contrast-induced Acute Kidney Injury Trial in Mexico City (Allopurinol, Febuxostat, Placebo)
Unknown status
- Contrast-induced Nephropathy
- Contrast-induced Acute Kidney Injury
- Allopurinol
- +2 more
-
Mexico City, México City, MexicoInstituto Nacional de Cardiologia Ignacio Chavez
Dec 5, 2018
Hyperuricemia With or Without Gout Trial in Tokyo (FYU-981, Febuxostat)
Completed
- Hyperuricemia With or Without Gout
- FYU-981
- Febuxostat
-
Tokyo, JapanMochida Investigational sites
Sep 21, 2018
Endothelial Dysfunction, Endstage Renal Disease Trial (Febuxostat, Placebo)
Completed
- Endothelial Dysfunction
- Endstage Renal Disease
- Febuxostat
- Placebo
- (no location specified)
Dec 28, 2017
Blood Pressure, Gout Trial in Jackson (febuxostat)
Terminated
- Blood Pressure
- Gout
- febuxostat
-
Jackson, MississippiUniversity of Mississippi Medical Center General Medicine/Hypert
Dec 13, 2017
Gout Flares Trial in Taipei (Placebo, AC-201, Febuxostat)
Completed
- Gout Flares
- Placebo
- +2 more
-
Taipei, TaiwanVeterans General Hospital
Apr 24, 2018
Adenine Phosphoribosyltransferase Deficiency Trial in Reykjavik (Allopurinol, Febuxostat)
Completed
- Adenine Phosphoribosyltransferase Deficiency
- Allopurinol
- Febuxostat
-
Reykjavik, IcelandLandspitali - The National University Hospital of Iceland
Dec 22, 2017
Type 1 Diabetes Trial in Toronto (Febuxostat)
Completed
- Type 1 Diabetes Mellitus
- Febuxostat
-
Toronto, Ontario, CanadaRenal Physiology Laboratory, University Health Network
Jan 11, 2018
Coronary Artery Disease Trial in Yokohama (Febuxostat)
Terminated
- Coronary Artery Disease
- Febuxostat
-
Yokohama, Kanagawa, JapanYokohama City University Medical Center
Aug 2, 2017